Teladoc (TDOC) Gets $7 Price Target: Can It Double?
Barclays has set a $7 price target on Teladoc as the company eyes growth from BetterHelp's insurance transition and s...
Compare safety profiles of SP500 and Total Market funds for retirement, focusing on diversification, drawdown risk, and historical resilience.
28,493 articlesBarclays has set a $7 price target on Teladoc as the company eyes growth from BetterHelp's insurance transition and s...
Aveanna's Q1 2026 results shed light on how the company is navigating labor costs, payer mix, and geographic expansio...
Apple posted record Q2 revenue and a rising Services segment, fueling bets on where AAPL could trade two years from n...
Netflix kept growing its revenue and user base, yet the stock stumbled. This article unpacks why the netflix stock fa...
A 22-year-old founder, backed by Lux Capital, is raising $30 million to launch American Perpetuals Exchange Corporati...
Apple just pulled back after a strong run, leaving investors wondering if now is the time to buy. This article uses h...
As Axogen prepares to report its Q4 2025 results, investors want clarity on growth, margins, and guidance. This artic...
Wall Street may be underestimating Micron's resilience. This-depth look explains why MU could surprise on the upside ...
Opendoor Technologies shares jumped about 6% as the company posted a strong Q4 and policy tailwinds boosted the stock...
Super Micro Computer reports revenue that more than doubles year over year, yet the shares sit flat as questions abou...
Tesla sits around $445 as Q1 margin gains meet AI roadmap momentum, prompting fresh Buy, Sell or Hold questions for i...
A broad rally in semiconductor stocks persists into late May 2026, driven by AI infrastructure demand. Yet history ca...